Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Medina Daniel

2. Date of Event Requiring Statement (MM/DD/YYYY) 11/27/2018

3. Issuer Name and Ticker or Trading Symbol

MEDICAL INNOVATION HOLDINGS, INC. [MIHI]

(Last) (First) (Middle)

11561 E. BEVERLY BLVD.

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

WHITTIER, CA 90601

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	37611	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series "A" Convertible Preferred Shares	⁽¹⁾	⁽¹⁾	Common Stock	15 ⁽²⁾ ⁽³⁾	⁽²⁾	D
Series "A" Convertible Preferred Shares	⁽¹⁾	⁽¹⁾	Common Stock	20 ⁽²⁾	⁽²⁾	I	Jointly with Madhava Rao Mankal ⁽⁴⁾

Explanation of Responses:
(1)	Not Applicable.
(2)	Each share of Series "A" Convertible Preferred Stock votes equivalent of the common stock - 1%. Due to administrative delays, the stock was not issued until December 21, 2018.
(3)	15 shares via repossession under purchase default. Due to administrative delays, the stock was not issued until December 21, 2018.
(4)	Combined vote 50% effectively through the 20 Series "A" Convertible Preferred Shares.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Medina Daniel 11561 E. BEVERLY BLVD. WHITTIER, CA 90601		X

Signatures
/s/ Daniel Medina		12/24/2018
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.